Signaron Pharma Private Limited
About Signaron Pharma Private Limited
Data last updated:
Signaron Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 23 November 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U47721DL2023PTC423023.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunil Razdan and Anjali Razdan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 487, Gh – 5/7 Paschim Vihar, New Delhi, Delhi, India – 110087.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Signaron Pharma Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressFlat No. 487, Gh – 5/7 Paschim Vihar, New Delhi, Delhi, India – 110087
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Signaron Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Signaron Pharma Private Limited, buy the company report.
Board of directors of Signaron Pharma Private Limited
Signaron Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Razdan | Director | 23 Nov 2023 | 2 Years 11 Months | Current |
| Anjali Razdan | Director | 23 Nov 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Signaron Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Signaron Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Signaron Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Signaron Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Anjali Razdan was appointed as Director on 23 Nov 2023.
Frequently asked questions
Signaron Pharma is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 23 November 2023 (3+ years old) and is registered under CIN U47721DL2023PTC423023.
Signaron Pharma has 2 current directors:
- Sunil Razdan - Director
- Anjali Razdan - Director
The latest financial statements of Signaron Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Signaron Pharma is U47721DL2023PTC423023. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Signaron Pharma was incorporated on 23 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Anjali Razdan was appointed as Director on 23 Nov 2023. Sunil Razdan was appointed as Director on 23 Nov 2023.
The registered office of Signaron Pharma is at Flat No. 487, Gh – 57 Paschim Vihar, New Delhi, Delhi, India – 110087.
The compliance status of Signaron Pharma is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.
Signaron Pharma can be reached at its registered office: Flat No. 487, Gh – 57 Paschim Vihar, New Delhi, Delhi, India – 110087.
Signaron Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
